期刊文献+

扩散峰度成像对早期帕金森病患者黑质微观结构变化的研究

The Study of Diffusion Kurtosis Imaging on Microstructural Changes of Substantianigra in Patients with Early Parkinson’s Disease
下载PDF
导出
摘要 目的:探讨扩散峰度成像(DKI)对早期帕金森病(PD)患者的脑黑质微观结构变化的诊断价值。方法:搜集30例早期PD患者作为PD组,20例健康志愿者作为对照组,均接受MRI常规序列及DKI检查,所有DKI扫描数据经后处理后,收集各定量参数图,三项参数分别是各向异性分数(FA)、平均扩散峰度(MK)及平均扩散率(MD),分别测量黑质的各项参数值,对各项参数值进行组间比较,分析其差异是否有统计学意义,并以受试者工作特征(ROC)曲线来评价DKI各参数值对早期PD患者的诊断效能。结果:PD组黑质FA值低于健康对照组;PD组黑质MD值与健康对照组无差异;PD组黑质MK值明显高于健康对照组。ROC曲线显示黑质FA值、MD值及MK值诊断早期PD的AUC分别为0.716、0.613和0.820,黑质MK值诊断早期PD患者具有一定准确性,诊断灵敏度、特异度高于FA值和MD值。结论:DKI可用于分析早期PD患者黑质微观结构的改变,其中MK值可以更好地反映早期PD患者黑质细微结构的变化信息。 Objective: To explore the diagnostic value of diffusion kurtosis imaging(DKI) the microstructure changes of substantianigra in patients with early Parkinson’s disease(PD). Methods: 30 patients with early PD were collected as the PD group while 20 healthy volunteers as the control group. All the subjects underwent brain routine magnetic resonance imaging(MRI) and DKI examination. The DKI scan data were processed to obtain quantitative parameter maps, with the three paramrters as fractional anisotropy(FA), mean diffusivity(MD) and mean kurtosis(MK). The DKI parameters of substantianigra(SN) were measured respectively and the differences between the two groups were statistically analyzed. The receiver operating characteristic(ROC) curve was used to evaluate the diagnostic efficacy of DKI parameters in patients with early PD. Results: The FA value of the substantianigra of the PD group was lower than that of the healthy control group, and the difference between the two groups was statistically significant. Compared with the healthy control group, the MD value of the substantianigra in the PD group was slightly higher, and the difference between the two groups was not statistically significant. The MK value of the substantianigra in the PD group was significantly higher than that in the healthy control group, and the difference between the two groups was statistically significant. The ROC curve showed the AUC of FA value, MD value and MK value in the substantianigra in the diagnosis of early PD were 0.716, 0.613 and 0.820, respectively. The substantianigra MK value showed certain accuracy in the diagnosis of early PD patients, and the diagnostic sensitivity and specificity were higher than the FA value and MD value. Conclusions:DKI can be used to analyze the changes of the microstructure of substantianigra in early PD patients, and the MK value can better reflect the changes of the microstructure of substantianigra in early PD patients.
作者 董家科 邓敏 杨涛 孔许强 刘康永 蔡思鹏 王涛 姆妮热·亚力昆 DONG Jiake;DENG Min;YANG Tao;KONG Xuqiang;LIU Kangyong;CAI Sipeng;WANG Tao;YALIKUN·Munire(The First People’s Hospital of Kashi Prefecture,Kashi 844000,China;Department of Imaging,Zhoupu Hospital,Affiliated to Shanghai University of Medicine&Health Sciences,Shanghai 201318,China;Department of neurology,Zhoupu Hospital,Affiliated to Shanghai University of Medicine&Health Sciences,Shanghai 201318,China;Image Center,ShacheCountyPeople’s Hospital of Kashi Prefecture,Shache 844799,China)
出处 《CT理论与应用研究(中英文)》 2022年第5期623-629,共7页 Computerized Tomography Theory and Applications
基金 上海市浦东新区卫健委项目(多模态磁共振技术联合双能LUNAR骨密度扫描在早期偏侧性帕金森病检测中的应用研究(PW2019A-26)) 上海市浦东新区卫计委重点学科建设基金(PWZxk2017-25)。
关键词 扩散峰度成像 早期帕金森病 黑质 diffusion kurtosis imaging early Parkinson’s disease substantianigra
  • 相关文献

参考文献7

二级参考文献52

  • 1张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:616
  • 2Zhang ZX, Roman GC, Hong Z,et al. Parkinson's disease inChina: prevalence in Beijing, Xian, and Shanghai[ J]. Lancet,2005,365(9459): 595-597.
  • 3Postuma RB, Berg D, Stem M, et al. MDS clinical diagnosticcriteria for Parkinson、disease[ J]. Mov Disord, 2015,30( 12):1591-1601. DOI: 10.1002/mds.26424.
  • 4Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motorsymptoms of Parkinson's disease : diagnosis and management[ J ].Lancet Neurol, 2006,5(3): 235-245.
  • 5Goetz CG,Tilley BC, Shaftman SR,et al. Movement DisorderSociety-sponsored revision of the Unified Parkinson; s DiseaseRating Scale ( MDS-UPDRS) . scale presentation and clinimetrictesting results [ J ]. Mov Disord, 2008 , 23 ( 15): 2129-2170.DOI: 10.1002/mds. 22340.
  • 6Shah M, Muhammed N, Findley LJ, et al. Olfactory tests in thediagnosis of essential tremor [ J ]. Parkinsonism Relat Disord,2008,14(7) : 563-568. DOI: 10. 1016/j. parkreldis. 2007. 12.006.
  • 7Wenning GK, Shephard B, Hawkes C, et al. Olfactory functionin atypical parkinsonian syndromes [ J ]. Acta NeurologicaScandinavica, 1995,91(4): 247-250.
  • 8Muller A, Mtingersdorf M, Reichmann H, et al. Olfactoryfunction in Parkinsonian syndromes[ J]. J Clin Neurosci, 2002 , 9(5): 521-524.
  • 9Goldstein DS,Holmes C,Bentho O,et al. Biomarkers to detectcentral dopamine deficiency and distinguish Parkinson diseasefrom multiple system atrophy [ J ]. Parkinsonism Relat Disord,2008,14(8): 600-607. DOI: 10. 1016/j. parkreldis. 2008. 01.010.
  • 10Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory functiondistinguishes vascular parkinsonism from Parkinson's disease[ J].J Neurol Neurosurg Psychiatry, 2004, 75(12) : 1749-1752.

共引文献1188

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部